 | AbbVie 2020: Company Background, Recent Earnings Review, Company Forecast, Company Profile and Clinical Trial Overview - PRNewswire
www.prnewswire.com - July 10 at 12:07 AM |
 | FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity
finance.yahoo.com - July 9 at 7:07 PM |
 | AbbVie Stands to Benefit from Affluenza - Nasdaq
www.nasdaq.com - July 9 at 9:06 AM |
 | Carlos Alban Sells 53,325 Shares of AbbVie Inc (NYSE:ABBV) Stock
www.marketbeat.com - July 9 at 5:52 AM |
| Better Buy: AbbVie vs. Biogen
finance.yahoo.com - July 8 at 8:59 AM |
| 6 Stocks to Wade Through the Spike in Coronavirus Cases
finance.yahoo.com - July 8 at 8:59 AM |
 | AbbVie Stands to Benefit from Affluenza - InvestorPlace
investorplace.com - July 7 at 7:03 PM |
| AbbVie to Host Second-Quarter 2020 Earnings Conference Call - Yahoo Finance
finance.yahoo.com - July 7 at 7:03 PM |
| AbbVie 2020: Company Background, Recent Earnings Review, Company Forecast, Company Profile and Clinical Trial Overview - Yahoo Finance
finance.yahoo.com - July 7 at 2:03 PM |
 | Should holders of Abbvie Inc expect a dividend payout?
uk.finance.yahoo.com - July 7 at 9:02 AM |
|
 | Global Medical Aesthetics Market (2020 to 2024) - Featuring 3M, AbbVie & Danaher Among Others - ResearchAndMarkets.com
www.businesswire.com - July 7 at 9:02 AM |
 | Biopharmaceutical Oral Drug Delivery Market COVID-19 Impact Forecast Study By Global Countries Data (2020-2029) | AbbVie and Amgen
www.marketwatch.com - July 7 at 9:02 AM |
 | Evolus Botox Rival Loses First Round Over AbbVie’s Allergan
www.msn.com - July 7 at 9:02 AM |
| Shareholders Of AbbVie (NYSE:ABBV) Must Be Happy With Their 75% Return
finance.yahoo.com - July 7 at 9:02 AM |
| AbbVie to Host Second-Quarter 2020 Earnings Conference Call
finance.yahoo.com - July 7 at 9:02 AM |
| AbbVie 2020: Company Background, Recent Earnings Review, Company Forecast, Company Profile and Clinical Trial Overview
www.prnewswire.com - July 7 at 7:10 AM |
| 4 Reasons to Own AbbVie Stock as Coronavirus Woes Linger - Yahoo Finance
finance.yahoo.com - July 6 at 6:49 PM |
| Musculoskeletal Disorders Therapeutics Market Set New Growth Story For Future Development By 2029 | Pfizer and AbbVie
www.marketwatch.com - July 6 at 1:49 PM |
| 4 Reasons to Own AbbVie Stock as Coronavirus Woes Linger
finance.yahoo.com - July 6 at 1:49 PM |
 | AbbVie Company Profile 2020: Explores the Company's Prescription Pharmaceutical Performance and Outlook Over 2019-2029 - GlobeNewswire
www.globenewswire.com - July 6 at 8:48 AM |
| AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
finance.yahoo.com - July 5 at 10:57 PM |
| AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run? - Nasdaq
www.nasdaq.com - July 3 at 1:23 PM |
 | 3 Reasons AbbVie Could Make You Rich - Seeking Alpha
seekingalpha.com - July 3 at 1:23 PM |
| AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run?
finance.yahoo.com - July 3 at 1:23 PM |
| 3 Reasons AbbVie Could Make You Rich
seekingalpha.com - July 3 at 10:46 AM |
 | Better Coronavirus Stock: Eli Lilly or AbbVie? - Motley Fool
www.fool.com - July 3 at 8:21 AM |
| Better Coronavirus Stock: Eli Lilly or AbbVie?
finance.yahoo.com - July 3 at 8:21 AM |
| Top Ranked Income Stocks to Buy for July 2nd
finance.yahoo.com - July 2 at 2:26 PM |
| Buy Pharma Giant AbbVie Stock for Growth, Income & Coronavirus Safety - Yahoo Finance
finance.yahoo.com - July 1 at 6:40 PM |
| What Makes AbbVie (ABBV) a New Strong Buy Stock - Yahoo Finance
finance.yahoo.com - July 1 at 6:40 PM |
|
| Buy Pharma Giant AbbVie Stock for Growth, Income & Coronavirus Safety
finance.yahoo.com - July 1 at 6:40 PM |
| What Makes AbbVie (ABBV) a New Strong Buy Stock
finance.yahoo.com - July 1 at 1:39 PM |
| AbbVie Combo Doesn’t Benefit Covid Patients, Study Finds
www.msn.com - June 30 at 7:05 PM |
| 3 Dividend Stocks to Buy for Second Half of 2020 for Coronavirus Safety
finance.yahoo.com - June 30 at 7:04 PM |
| AbbVie Inc (NYSE:ABBV) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 30 at 2:04 PM |
 | AbbVie Combo Doesn’t Benefit Covid Patients, Study Finds - Bloomberg
www.bloomberg.com - June 29 at 11:47 PM |
| Were Hedge Funds Right About Piling Into AbbVie Inc (ABBV)? - Yahoo Finance
finance.yahoo.com - June 29 at 1:46 PM |
| Were Hedge Funds Right About Piling Into AbbVie Inc (ABBV)?
finance.yahoo.com - June 29 at 1:46 PM |
| AbbVie (NYSE:ABBV) PT Raised to $110.00
www.americanbankingnews.com - June 29 at 9:30 AM |
 | Mizuho Raises AbbVie (NYSE:ABBV) Price Target to $110.00
www.marketbeat.com - June 29 at 8:54 AM |
| AbbVie: This Blue Chip Name Offers Strong Double Digit Total Returns - Seeking Alpha
seekingalpha.com - June 28 at 12:57 PM |
| AbbVie: This Blue Chip Name Offers Strong Double Digit Total Returns
seekingalpha.com - June 28 at 12:34 PM |
| FDA Rejects AbbVie's Macular Degeneration Drug Abicipar Pegol
www.fool.com - June 28 at 7:56 AM |
| AbbVie: Stock Remains Extremely Attractive Despite Recent Price Appreciation
seekingalpha.com - June 26 at 12:48 PM |
| AbbVie's Eye Disorder Candidate Gets Complete Response Letter
finance.yahoo.com - June 26 at 12:48 PM |
| August 7th Options Now Available For AbbVie (ABBV)
www.nasdaq.com - June 26 at 7:40 AM |
| AbbVie: FDA Issues Complete Response Letter To BLA For Abicipar Pegol
www.nasdaq.com - June 26 at 7:40 AM |
 | BRIEF-Allergan, An Abbvie Company, And Molecular Partners Receive CRL From FDA On Biologics License Application For Abicipar Pegol
www.reuters.com - June 26 at 7:40 AM |
| How gene therapy and CRISPR are helping to cure blindness
finance.yahoo.com - June 25 at 3:05 PM |
| Sosei, AbbVie sign drug discovery deal worth up to $1 billion
finance.yahoo.com - June 25 at 10:03 AM |
